HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Galectin-3 facilitates cell motility in gastric cancer by up-regulating protease-activated receptor-1 (PAR-1) and matrix metalloproteinase-1 (MMP-1).

AbstractBACKGROUND:
Galectin-3 is known to regulate cancer metastasis. However, the underlying mechanism has not been defined. Through the DNA microarray studies after galectin-3 silencing, we demonstrated here that galectin-3 plays a key role in up-regulating the expressions of protease-activated receptor-1 (PAR-1) and matrix metalloproteinase-1 (MMP-1) PAR-1 thereby promoting gastric cancer metastasis.
METHODOLOGY/PRINCIPAL FINDINGS:
We examined the expression levels of Galectin-3, PAR-1, and MMP-1 in gastric cancer patient tissues and also the effects of silencing these proteins with specific siRNAs and of over-expressing them using specific lenti-viral constructs. We also employed zebrafish embryo model for analysis of in vivo gastric cancer cell invasion. These studies demonstrated that: a) galectin-3 silencing decreases the expression of PAR-1. b) galectin-3 over-expression increases cell migration and invasion and this increase can be reversed by PAR-1 silencing, indicating that galectin-3 increases cell migration and invasion via PAR-1 up-regulation. c) galectin-3 directly interacts with AP-1 transcriptional factor, and this complex binds to PAR-1 promoter and drives PAR-1 transcription. d) galectin-3 also amplifies phospho-paxillin, a PAR-1 downstream target, by increasing MMP-1 expression. MMP-1 silencing blocks phospho-paxillin amplification and cell invasion caused by galectin-3 over-expression. e) Silencing of either galectin-3, PAR-1 or MMP-1 significantly reduced cell migration into the vessels in zebrafish embryo model. f) Galectin-3, PAR-1, and MMP-1 are highly expressed and co-localized in malignant tissues from gastric cancer patients.
CONCLUSIONS/SIGNIFICANCE:
Galectin-3 plays the key role of activating cell surface receptor through production of protease and boosts gastric cancer metastasis. Galectin-3 has the potential to serve as a useful pharmacological target for prevention of gastric cancer metastasis.
AuthorsSeok-Jun Kim, Ji-Young Shin, Kang-Duck Lee, Young-Ki Bae, Il-Ju Choi, Seok Hee Park, Kyung-Hee Chun
JournalPloS one (PLoS One) Vol. 6 Issue 9 Pg. e25103 ( 2011) ISSN: 1932-6203 [Electronic] United States
PMID21966428 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
Chemical References
  • Galectin 3
  • Receptor, PAR-1
  • Matrix Metalloproteinase 1
Topics
  • Animals
  • Blotting, Western
  • Cell Line, Tumor
  • Cell Movement (genetics, physiology)
  • Chromatin Immunoprecipitation
  • Galectin 3 (genetics, metabolism)
  • Genetic Vectors (genetics)
  • Humans
  • Immunohistochemistry
  • Immunoprecipitation
  • In Vitro Techniques
  • Lentivirus (genetics)
  • Matrix Metalloproteinase 1 (genetics, metabolism)
  • Oligonucleotide Array Sequence Analysis
  • Receptor, PAR-1 (genetics, metabolism)
  • Reverse Transcriptase Polymerase Chain Reaction
  • Stomach Neoplasms (genetics, metabolism)
  • Zebrafish

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: